Leveraging the Power of Biotherapeutics to Address Unmet Medical Needs in CNS Diseases
Time: 1:40 pm
day: Day One Mid Day
Details:
- Evidencing how significant progress in the understanding of the biology of the bloodbrain-barrier has enabled biologics to become a viable modality for CNS diseases
- Augmenting therapeutic efficacy of 2nd generation of approved Biologics Safe, through effective CNS shuttle platforms
- Outlining key differences that exist in the delivery of protein therapeutics versus nucleic acid medicine into the brain